Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Blood

• Publication date

  2009-10-22

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2009-03-208017PMID 19706888
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Graft-Versus-Host Disease

  2016cited by this paper
• Tumorigenesis and Neoplastic Progression Focal Adhesion Kinase-Related Proline-Rich Tyrosine Kinase 2 and Focal Adhesion Kinase Are Co-Overexpressed in Early-Stage and Invasive ErbB2-Positive Breast Cancer and Cooperate for Breast Cancer Cell Tumorigenesis and Invasiveness

  2010cited by this paper
• HapMap scanning of novel human minor histocompatibility antigens.

  2008cited by this paper
• HapMap scanning of novel human minor histocompatibility antigens

  2008cited by this paper
• National Center for Biotechnology Information

  2008cited by this paper
• Identification of phosphatidylinositol 4-kinase type II β as HLA class II-restricted target in graft versus leukemia reactivity

  2008cited by this paper
• HLA-DP as specific target for cellular immunotherapy in HLA class II-expressing B-cell leukemia

  2008cited by this paper
• Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19-encoded minor histocompatibility antigen using a novel genome-wide analysis

  2008cited by this paper
• Peptide epitope identification for tumor-reactive CD4 T cells.

  2008cited by this paper
• Genetic engineering of virus-specific T cells with T-cell receptors recognizing minor histocompatibility antigens for clinical application

  2008cited by this paper
• The known unknowns of antigen processing and presentation

  2008cited by this paper
• Identification of human minor histocompatibility antigens based on genetic association with highly parallel genotyping of pooled DNA.

  2008cited by this paper
• Essential role of Pyk2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells

  2008cited by this paper
• Early detection and rapid isolation of leukemia-reactive donor T cells for adoptive transfer using the IFN-gamma secretion assay.

  2007cited by this paper
• Alternative splicing due to an intronic SNP in HMSD generates a novel minor histocompatibility antigen.

  2007cited by this paper
• The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence

  2007cited by this paper
• Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reduced-intensity transplantation.

  2007cited by this paper
• Early Detection and Rapid Isolation of Leukemia-Reactive Donor T Cells for Adoptive Transfer Using the IFN-γ Secretion Assay

  2007cited by this paper
• Graft-versus-host disease

  2007cited by this paper
• Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) gene.

  2007cited by this paper
• The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL.

  2006cited by this paper
• An Antigen Produced by Splicing of Noncontiguous Peptides in the Reverse Order

  2006cited by this paper
• A novel approach to identify antigens recognized by CD4 T cells using complement-opsonized bacteria expressing a cDNA library

  2005cited by this paper
• Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer.

  2005cited by this paper
• A frameshift polymorphism in P2X5 elicits an allogeneic cytotoxic T lymphocyte response associated with remission of chronic myeloid leukemia.

  2005cited by this paper
• Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.

  2004cited by this paper
• Minor Histocompatibility Antigen DBY Elicits a Coordinated B and T Cell Response after Allogeneic Stem Cell Transplantation

  2004cited by this paper
• Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cells

  2004cited by this paper
• Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia

  2003cited by this paper
• The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoprotein.

  2003cited by this paper
• Immunobiology of acute graft-versus-host disease.

  2003cited by this paper
• Identification and monitoring of graft-versus-host specific T-cell clone in stem cell transplantation.

  2003cited by this paper
• A Human Minor Histocompatibility Antigen Resulting from Differential Expression due to a Gene Deletion

  2003cited by this paper
• Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

  2003cited by this paper
• Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor β loci sequences

  2003cited by this paper
• Minor histocompatibility antigens in human stem cell transplantation.

  2003cited by this paper
• Identification of a Polymorphic Gene, BCL2A1, Encoding Two Novel Hematopoietic Lineage-specific Minor Histocompatibility Antigens

  2003cited by this paper
• CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes

  2003cited by this paper
• The role of Aktand RAFTK in beta1 integrin mediated survival of precursor B-acute lymphoblastic leukemia cells.

  2002cited by this paper
• The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.

  2002cited by this paper
• Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion.

  2002cited by this paper
• CD4(+) bias in T cells cloned from a CML patient with active graft versus leukemia effect.

  2002cited by this paper
• The Role of AKT and RAFTK in β1 Integrin Mediated Survival of Precursor B-acute Lymphoblastic Leukemia Cells

  2002cited by this paper
• The Immunogenicity of a New Human Minor Histocompatibility Antigen Results from Differential Antigen Processing

  2001cited by this paper
• Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia.

  2000cited by this paper
• A Human Minor Histocompatibility Antigen Specific for B Cell Acute Lymphoblastic Leukemia

  1999cited by this paper
• RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells

  1999cited by this paper
• CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity.

  1998cited by this paper
• The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism.

  1998cited by this paper
• Generation of cDNA expression libraries enriched for in-frame sequences.

  1997cited by this paper
• Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

  1997cited by this paper
• Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

  1995cited by this paper
• Identification of a graft versus host disease-associated human minor histocompatibility antigen.

  1995cited by this paper
• Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity.

  1995cited by this paper
• Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia.

  1994cited by this paper
• Graft-versus-host disease.

  1991cited by this paper
• Immunobiology of acute graft-versus-host disease.

  1987cited by this paper

• Selective H2-O tissue expression reduces risk for graft-versus-host disease in an in vivo transplantation model.

  2025cites this paper
• Mutated DNMT3A creates a public HLADQ- binding neoantigen on acute myeloid leukemia

  2025cites this paper
• Molecular Insights Into MR1‐Mediated T Cell Immunity: Lessons Learned and Unanswered Questions

  2025cites this paper
• High-Resolution HLA-DRB1 Allele Frequencies in a Romanian Cohort of Stem Cell Donors

  2024cites this paper
• MAIT cell-MR1 reactivity is highly conserved across multiple divergent species

  2024cites this paper
• The delicate balance of graft versus leukemia and graft versus host disease after allogeneic hematopoietic stem cell transplantation

  2023cites this paper
• γδ T, NKT, and MAIT Cells During Evolution: Redundancy or Specialized Functions?

  2022cites this paper
• MR1 encompasses at least six allele groups with coding region alterations

  2021influential citation
• Influence of DM-sensitivity on immunogenicity of MHC class II restricted antigens

  2021cites this paper
• A redox probe screens MTHFD1 as a determinant of gemcitabine chemoresistance in cholangiocarcinoma

  2021cites this paper
• Deciphering the role of Minor histocompatibility antigens for acute graft-versus-host disease.

  2021cites this paper
• T-Cell Immunotherapy: From Synthetic Biology to Clinical Practice

  2020cites this paper
• Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase

  2020cites this paper
• HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study

  2020cites this paper
• Epidemiology and biology of relapse after stem cell transplantation

  2018cites this paper
• Natural T‐cell ligands that are created by genetic variants can be transferred between cells by extracellular vesicles

  2018cites this paper
• CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class II

  2018cites this paper
• Single step multiple genotyping by MALDI-TOF mass spectrometry, for evaluation of minor histocompatibility antigens in patients submitted to allogeneic stem cell transplantation from HLA-matched related and unrelated donor

  2017influential citation
• Cell therapies for hematological malignancies: don't forget non-gene-modified t cells!

  2017cites this paper
• Graft-versus-Leukemia Effect Following Hematopoietic Stem Cell Transplantation for Leukemia

  2017cites this paper
• Hematopoietic stem cell transplantation and cellular therapy

  2017cites this paper
• Discovery of minor histocompatibility antigens as targets for immunotherapy

  2016cites this paper
• Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets

  2016influential citation
• Microarray Gene Expression Analysis to Evaluate Cell Type Specific Expression of Targets Relevant for Immunotherapy of Hematological Malignancies

  2016cites this paper
• Minor histocompatibility Ags: identification strategies, clinical results and translational perspectives

  2016cites this paper
• Characterization and recognition of minor histocompatibility antigens

  2016cites this paper
• Allogeneic and Autologous T cell Strategies to Enhance Targeting of Acute Myeloid Leukemias

  2015cites this paper
• Directed T-cell therapies for leukemia and lymphoma after hematopoietic stem cell transplant: beyond chimeric antigen receptors

  2015cites this paper
• Allo‐reactive T cells for the treatment of hematological malignancies

  2015cites this paper
• Allogeneic T cells: maestro in the co-ordination of the immune response after hematopoietic stem cell transplantation

  2014influential citation
• Moving towards patient-centered decision-making in chronic myeloid leukemia: assessment of quality of life and symptom burden

  2014cites this paper
• Naïve subset develops the most important alloreactive response among human CD4+ T lymphocytes in Human Leukocyte Antigen‐identical related setting

  2014cites this paper
• CD4(+)and CD8(+)T-cell reactions against leukemia-associated- or minor-histocompatibility-antigens in AML-patients after allogeneic SCT.

  2014cites this paper
• Minor histocompatibility antigens: past, present, and future.

  2014cites this paper
• Development of a coordinated allo T cell and auto B cell response against autosomal PTK2B after allogeneic hematopoietic stem cell transplantation

  2014cites this paper
• Adoptive T-cell therapy for Leukemia

  2014cites this paper
• Molecular typing methods for minor histocompatibility antigens.

  2014cites this paper
• Cytotoxic T lymphocytes for leukemia and lymphoma.

  2014cites this paper
• Human leukocyte antigen-DO regulates surface presentation of human leukocyte antigen class II-restricted antigens on B cell malignancies.

  2014cites this paper
• Whole exome sequencing to estimate alloreactivity potential between donors and recipients in stem cell transplantation

  2014cites this paper
• Immunological characteristics of human umbilical cord mesenchymal stem cells and the therapeutic effects of their transplantion on hyperglycemia in diabetic rats

  2013influential citation
• Donor T cells administered over HLA class II barriers mediate antitumor immunity without broad off-target toxicity in a NOD/scid mouse model of acute leukemia.

  2013cites this paper
• Isolation of Human CD4/CD8 Double-Positive, Graft-Versus-Host Disease–Protective, Minor Histocompatibility Antigen–Specific Regulatory T Cells and of a Novel HLA-DR7–Restricted HY-Specific CD4 Clone

  2013cites this paper
• Minor Histocompatibility Antigens and the Maternal Immune Response to the Fetus During Pregnancy

  2013cites this paper
• Patient HLA-DP-specific CD4+ T cells from HLA-DPB1-mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease.

  2013cites this paper
• The Impact of Minor Histocompatibility Antigens in Allogeneic Stem Cell Transplantation

  2013cites this paper
• Minor histocompatibility antigen typing by DNA sequencing for clinical practice in hematopoietic stem-cell transplantation.

  2012cites this paper
• Human allo-reactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemia

  2012cites this paper
• Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity

  2012cites this paper
• Immunotherapeutic approaches to improve graft-versus-tumor effect and reduce graft-versus-host disease.

  2012cites this paper
• Major and Minor Histocompatibility Antigens to Non-Inherited Maternal Antigens (NIMA)

  2012cites this paper
• Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation

  2012cites this paper
• Diversifying the MHC peptide portfolio.

  2012cites this paper
• Long-Term Tolerance to Kidney Allografts After Induced Rejection of Donor Hematopoietic Chimerism in a Preclinical Canine Model

  2012cites this paper
• Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO.

  2012cites this paper
• Graft versus leukemia reactivity after allogeneic stem cell transplantation.

  2011cites this paper
• Designing T-cells with desired T-cell receptor make-up for immunotherapy

  2011cites this paper
• Studies on the immunogenicity of tumour associated antigens in leukaemia

  2011cites this paper
• Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia

  2011cites this paper
• HLA-DPB1 mismatching results in the generation of a full repertoire of HLA-DPB1-specific CD4+ T cell responses showing immunogenicity of all HLA-DPB1 alleles.

  2010cites this paper
• Degree of predicted minor histocompatibility antigen mismatch correlates with poorer clinical outcomes in nonmyeloablative allogeneic hematopoietic cell transplantation.

  2010cites this paper
• h-Throughput Characterization of 10 New Minor ocompatibility Antigens by Whole Genome

  2010cites this paper
• Role of MHC restriction in allogeneic immune responses to cancer

  2010cites this paper
• Eradication of Medullary Multiple Myeloma by CD4+ Cytotoxic Human T Lymphocytes Directed at a Single Minor Histocompatibility Antigen

  2010cites this paper
• Clinical Cancer esearch cer Therapy : Preclinical dication of Medullary Multiple Myeloma by CD 4 + Cytotoxic an T Lymphocytes Directed at a Single Minor R ocompatibility Antigen

  2010cites this paper
• Allo-HLA reactivity of virus-specific memory T cells is common.

  2010cites this paper
• NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction.

  2010cites this paper
• High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning.

  2010cites this paper
• Cancer esearch oenvironment and Immunology h-Throughput Characterization of 10 New Minor ocompatibility Antigens by Whole Genome R ociation Scanning

  2010cites this paper
• Identification of MHC II-Restricted Minor Histocompatibility Antigens After HLA-Identical Stem-Cell Transplantation

  2010cites this paper